Back to User profile » Dr Claus F Vogelmeier

Papers published by Dr Claus F Vogelmeier:


Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting

Halpin DM, Rothnie KJ, Banks V, Czira A, Compton C, Wood R, Tritton T, Massey O, Wild R, Snowise N, Nikitin K, Sharma R, Ismaila AS, Vogelmeier CF

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2417-2429

Published Date: 24 September 2022

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

Alter P, Kahnert K, Trudzinski FC, Bals R, Watz H, Speicher T, Söhler S, Andreas S, Welte T, Rabe KF, Wouters EFM, Sassmann-Schweda A, Wirtz H, Ficker JH, Vogelmeier CF, Jörres RA

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1703-1713

Published Date: 29 July 2022

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET

Fischer C, Jörres RA, Alter P, Trudzinski FC, Yildirim, Bals R, Vogelmeier CF, Kauffmann-Guerrero D, Behr J, Watz H, Holle R, Kahnert K

Patient Preference and Adherence 2022, 16:1759-1770

Published Date: 26 July 2022

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model

Shukla S, Shah D, Martin A, Risebrough NA, Kendall R, Vogelmeier CF, Boucot I, Tombs L, Bjermer L, Jones PW, Kerwin E, Compton C, Maltais F, Lipson DA, Ismaila AS

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3105-3118

Published Date: 13 November 2021

Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial

Bjermer L, Boucot IH, Maltais F, Kerwin EM, Naya IP, Tombs L, Jones PW, Compton C, Lipson DA, Vogelmeier CF

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1939-1956

Published Date: 28 June 2021

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement

Vogelmeier CF, Naya IP, Maltais F, Bjermer L, Kerwin EM, Tombs L, Jones PW, Compton C, Lipson DA, Boucot IH

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1215-1226

Published Date: 3 May 2021

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis

Veith M, Tüffers J, Peychev E, Klemmer A, Kotke V, Janciauskiene S, Wilhelm S, Bals R, Koczulla AR, Vogelmeier CF, Greulich T

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2827-2836

Published Date: 6 November 2020